Anand Devaraj
Overview
Explore the profile of Anand Devaraj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
150
Citations
4575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Xu Y, Padley S, Devaraj A, Desai S, Ridge C
Cardiovasc Intervent Radiol
. 2024 Feb;
47(5):613-620.
PMID: 38361010
Purpose: Several factors are known to affect lung ablation zones. Questions remain as to why there are discrepancies between achieved and vendor-predicted ablation zones and what contributing factors can be...
12.
Margaritopoulos G, Proklou A, Trachalaki A, Badenes Bonet D, Kokosi M, Kouranos V, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38348245
Background: Overnight desaturation predicts poor prognosis across interstitial lung diseases (ILDs). The aim of the present study was to investigate whether nocturnal desaturation is associated with pulmonary vasculopathy and mortality....
13.
Desai S, Sivarasan N, Johannson K, George P, Culver D, Devaraj A, et al.
Lancet Respir Med
. 2023 Dec;
12(5):409-418.
PMID: 38104579
One view of sarcoidosis is that the term covers many different diseases. However, no classification framework exists for the future exploration of pathogenetic pathways, genetic or trigger predilections, patterns of...
14.
Hannah J, Lawrence A, Martinovic J, Naqvi M, Chua F, Kouranos V, et al.
Rheumatology (Oxford)
. 2023 Dec;
63(11):3080-3090.
PMID: 38039151
Objectives: The impact of autoantibody profiles on the prognosis for idiopathic inflammatory myositis-associated interstitial lung disease (IIM-ILD) and myositis spectrum ILD with myositis-specific antibodies (MSAs) remains unclear. This retrospective cohort...
15.
Hunter B, Argyros C, Inglese M, Linton-Reid K, Pulzato I, Nicholson A, et al.
Br J Cancer
. 2023 Nov;
129(12):1949-1955.
PMID: 37932513
Background: Methods to improve stratification of small (≤15 mm) lung nodules are needed. We aimed to develop a radiomics model to assist lung cancer diagnosis. Methods: Patients were retrospectively identified...
16.
Creamer A, Horst C, Dickson J, Tisi S, Hall H, Verghese P, et al.
Chest
. 2023 Nov;
165(4):1020-1024.
PMID: 37914027
No abstract available.
17.
Williams P, Philip K, Buttery S, Perkins A, Chan L, Bartlett E, et al.
Thorax
. 2023 Oct;
79(3):269-273.
PMID: 37875371
Background: Immediate smoking cessation interventions delivered alongside targeted lung health checks (TLHCs) to screen for lung cancer increase self-reported abstinence at 3 months. The impact on longer term, objectively confirmed...
18.
ODowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, et al.
Eur J Cardiothorac Surg
. 2023 Oct;
64(4).
PMID: 37804174
Background: Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted...
19.
ODowd E, Tietzova I, Bartlett E, Devaraj A, Biederer J, Brambilla M, et al.
Eur Respir J
. 2023 Oct;
62(4).
PMID: 37802631
Background: Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted...
20.
Barnett J, Maher T, Quint J, Adamson A, Wu Z, Smith D, et al.
Am J Respir Crit Care Med
. 2023 Sep;
208(9):975-982.
PMID: 37672028
Identifying patients with pulmonary fibrosis (PF) at risk of progression can guide management. To explore the utility of combining baseline BAL and computed tomography (CT) in differentiating progressive and nonprogressive...